Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 68 entries
Sorted by: Best Match Show Resources per page
Reply to the Editor-Precordial R' wave: electrical disturbance-based or abnormal substrate-based?.

Heart rhythm

Hoogendoorn JC, Zeppenfeld K.
PMID: 34339845
Heart Rhythm. 2021 Nov;18(11):2023-2024. doi: 10.1016/j.hrthm.2021.07.063. Epub 2021 Jul 30.

No abstract available.

Cite
Hoogendoorn JC, Zeppenfeld K. Reply to the Editor-Precordial R' wave: electrical disturbance-based or abnormal substrate-based?. Heart Rhythm. 2021;18(11):2023-2024doi: 10.1016/j.hrthm.2021.07.063.
Hoogendoorn, J. C., & Zeppenfeld, K. (2021). Reply to the Editor-Precordial R' wave: electrical disturbance-based or abnormal substrate-based?. Heart rhythm, 18(11), 2023-2024. https://doi.org/10.1016/j.hrthm.2021.07.063
Hoogendoorn, Jarieke C, and Zeppenfeld, Katja. "Reply to the Editor-Precordial R' wave: electrical disturbance-based or abnormal substrate-based?." Heart rhythm vol. 18,11 (2021): 2023-2024. doi: https://doi.org/10.1016/j.hrthm.2021.07.063
Hoogendoorn JC, Zeppenfeld K. Reply to the Editor-Precordial R' wave: electrical disturbance-based or abnormal substrate-based?. Heart Rhythm. 2021 Nov;18(11):2023-2024. doi: 10.1016/j.hrthm.2021.07.063. Epub 2021 Jul 30. PMID: 34339845.
Copy Download .nbib Format: NLM
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Blood

Kemps PG, Picarsic J, Durham BH, Hélias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, van de Wetering MD, van Noesel CJM, van Laar JAM, Verdijk RM, Flucke UE, Hogendoorn PCW, Woei-A-Jin FJSH, Sciot R, Beilken A, Feuerhake F, Ebinger M, Möhle R, Fend F, Bornemann A, Wiegering V, Ernestus K, Méry T, Gryniewicz-Kwiatkowska O, Dembowska-Baginska B, Evseev DA, Potapenko V, Baykov VV, Gaspari S, Rossi S, Gessi M, Tamburrini G, Héritier S, Donadieu J, Bonneau-Lagacherie J, Lamaison C, Farnault L, Fraitag S, Jullié ML, Haroche J, Collin M, Allotey J, Madni M, Turner K, Picton S, Barbaro PM, Poulin A, Tam IS, El Demellawy D, Empringham B, Whitlock JA, Raghunathan A, Swanson AA, Suchi M, Brandt JM, Yaseen NR, Weinstein JL, Eldem I, Sisk BA, Sridhar V, Atkinson M, Massoth LR, Hornick JL, Alexandrescu S, Yeo KK, Petrova-Drus K, Peeke SZ, Muñoz-Arcos LS, Leino DG, Grier DD, Lorsbach R, Roy S, Kumar AR, Garg S, Tiwari N, Schafernak KT, Henry MM, van Halteren AGS, Abla O, Diamond EL, Emile JF.
PMID: 34727172
Blood. 2022 Jan 13;139(2):256-280. doi: 10.1182/blood.2021013338.

ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in 3 infants with multisystemic disease involving the liver and hematopoietic system. This entity has subsequently been documented in case reports and series to occupy a...

Cite
Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280doi: 10.1182/blood.2021013338.
Kemps, P. G., Picarsic, J., Durham, B. H., Hélias-Rodzewicz, Z., Hiemcke-Jiwa, L., van den Bos, C., van de Wetering, M. D., van Noesel, C. J. M., van Laar, J. A. M., Verdijk, R. M., Flucke, U. E., Hogendoorn, P. C. W., Woei-A-Jin, F. J. S. H., Sciot, R., Beilken, A., Feuerhake, F., Ebinger, M., Möhle, R., Fend, F., Bornemann, A., Wiegering, V., Ernestus, K., Méry, T., Gryniewicz-Kwiatkowska, O., Dembowska-Baginska, B., Evseev, D. A., Potapenko, V., Baykov, V. V., Gaspari, S., Rossi, S., Gessi, M., Tamburrini, G., Héritier, S., Donadieu, J., Bonneau-Lagacherie, J., Lamaison, C., Farnault, L., Fraitag, S., Jullié, M. L., Haroche, J., Collin, M., Allotey, J., Madni, M., Turner, K., Picton, S., Barbaro, P. M., Poulin, A., Tam, I. S., El Demellawy, D., Empringham, B., Whitlock, J. A., Raghunathan, A., Swanson, A. A., Suchi, M., Brandt, J. M., Yaseen, N. R., Weinstein, J. L., Eldem, I., Sisk, B. A., Sridhar, V., Atkinson, M., Massoth, L. R., Hornick, J. L., Alexandrescu, S., Yeo, K. K., Petrova-Drus, K., Peeke, S. Z., Muñoz-Arcos, L. S., Leino, D. G., Grier, D. D., Lorsbach, R., Roy, S., Kumar, A. R., Garg, S., Tiwari, N., Schafernak, K. T., Henry, M. M., van Halteren, A. G. S., Abla, O., Diamond, E. L., & Emile, J. F. (2022). ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood, 139(2), 256-280. https://doi.org/10.1182/blood.2021013338
Kemps, Paul G, et al. "ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition." Blood vol. 139,2 (2022): 256-280. doi: https://doi.org/10.1182/blood.2021013338
Kemps PG, Picarsic J, Durham BH, Hélias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, van de Wetering MD, van Noesel CJM, van Laar JAM, Verdijk RM, Flucke UE, Hogendoorn PCW, Woei-A-Jin FJSH, Sciot R, Beilken A, Feuerhake F, Ebinger M, Möhle R, Fend F, Bornemann A, Wiegering V, Ernestus K, Méry T, Gryniewicz-Kwiatkowska O, Dembowska-Baginska B, Evseev DA, Potapenko V, Baykov VV, Gaspari S, Rossi S, Gessi M, Tamburrini G, Héritier S, Donadieu J, Bonneau-Lagacherie J, Lamaison C, Farnault L, Fraitag S, Jullié ML, Haroche J, Collin M, Allotey J, Madni M, Turner K, Picton S, Barbaro PM, Poulin A, Tam IS, El Demellawy D, Empringham B, Whitlock JA, Raghunathan A, Swanson AA, Suchi M, Brandt JM, Yaseen NR, Weinstein JL, Eldem I, Sisk BA, Sridhar V, Atkinson M, Massoth LR, Hornick JL, Alexandrescu S, Yeo KK, Petrova-Drus K, Peeke SZ, Muñoz-Arcos LS, Leino DG, Grier DD, Lorsbach R, Roy S, Kumar AR, Garg S, Tiwari N, Schafernak KT, Henry MM, van Halteren AGS, Abla O, Diamond EL, Emile JF. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022 Jan 13;139(2):256-280. doi: 10.1182/blood.2021013338. PMID: 34727172.
Copy Download .nbib Format: NLM
A New Surgical Technique for Internal Shoulder Contractures Secondary to Obstetric Brachial Plexus Injury: An Anterior Coracohumeral Ligament Release.

Journal of brachial plexus and peripheral nerve injury

Sarac C, Hogendoorn S, Nelissen RGHH.
PMID: 31413723
J Brachial Plex Peripher Nerve Inj. 2019 Aug 13;14(1):e35-e38. doi: 10.1055/s-0039-1693746. eCollection 2019 Jan.

No abstract available.

Cite
Sarac C, Hogendoorn S, Nelissen RGHH. A New Surgical Technique for Internal Shoulder Contractures Secondary to Obstetric Brachial Plexus Injury: An Anterior Coracohumeral Ligament Release. J Brachial Plex Peripher Nerve Inj. 2019;14(1):e35-e38doi: 10.1055/s-0039-1693746.
Sarac, C., Hogendoorn, S., & Nelissen, R. G. H. H. (2019). A New Surgical Technique for Internal Shoulder Contractures Secondary to Obstetric Brachial Plexus Injury: An Anterior Coracohumeral Ligament Release. Journal of brachial plexus and peripheral nerve injury, 14(1), e35-e38. https://doi.org/10.1055/s-0039-1693746
Sarac, C, et al. "A New Surgical Technique for Internal Shoulder Contractures Secondary to Obstetric Brachial Plexus Injury: An Anterior Coracohumeral Ligament Release." Journal of brachial plexus and peripheral nerve injury vol. 14,1 (2019): e35-e38. doi: https://doi.org/10.1055/s-0039-1693746
Sarac C, Hogendoorn S, Nelissen RGHH. A New Surgical Technique for Internal Shoulder Contractures Secondary to Obstetric Brachial Plexus Injury: An Anterior Coracohumeral Ligament Release. J Brachial Plex Peripher Nerve Inj. 2019 Aug 13;14(1):e35-e38. doi: 10.1055/s-0039-1693746. eCollection 2019 Jan. PMID: 31413723; PMCID: PMC6692147.
Copy Download .nbib Format: NLM
Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases.

Annals of diagnostic pathology

Yang L, Zhang H, Zhang X, Tang Y, Wu Z, Wang Y, Huang H, Fu X, Liu J, Hogendoorn PCW, Cheng H.
PMID: 34995868
Ann Diagn Pathol. 2021 Dec 23;57:151882. doi: 10.1016/j.anndiagpath.2021.151882. Epub 2021 Dec 23.

GCTB is an osteolytic, locally-aggressive, rarely-metastasizing tumour, characterized by abundance of osteoclast-like giant cells, induced by neoplastic mononuclear cells expressing high-levels of the receptor activator of nuclear factor Kappa-B ligand (RANKL), a mediator of osteoclast activation. Although the mainstay...

Cite
Yang L, Zhang H, Zhang X, et al. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases. Ann Diagn Pathol. 2021;57:151882doi: 10.1016/j.anndiagpath.2021.151882.
Yang, L., Zhang, H., Zhang, X., Tang, Y., Wu, Z., Wang, Y., Huang, H., Fu, X., Liu, J., Hogendoorn, P. C. W., & Cheng, H. (2021). Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases. Annals of diagnostic pathology, 57151882. https://doi.org/10.1016/j.anndiagpath.2021.151882
Yang, Li, et al. "Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases." Annals of diagnostic pathology vol. 57 (2021): 151882. doi: https://doi.org/10.1016/j.anndiagpath.2021.151882
Yang L, Zhang H, Zhang X, Tang Y, Wu Z, Wang Y, Huang H, Fu X, Liu J, Hogendoorn PCW, Cheng H. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases. Ann Diagn Pathol. 2021 Dec 23;57:151882. doi: 10.1016/j.anndiagpath.2021.151882. Epub 2021 Dec 23. PMID: 34995868.
Copy Download .nbib Format: NLM
Formation of molecular monolayers on TiO2 surfaces: a surface analogue of the Williamson ether synthesis.

Langmuir : the ACS journal of surfaces and colloids

Chen J, Franking R, Ruther RE, Tan Y, He X, Hogendoorn SR, Hamers RJ.
PMID: 21528935
Langmuir. 2011 Jun 07;27(11):6879-89. doi: 10.1021/la2008528. Epub 2011 May 02.

Strategies to modify metal oxide surfaces are important because of the increasing applications of metal oxides in catalysis, sensing, electronics, and renewable energy. Here, we report the formation of molecular monolayers on anatase nanocrystalline TiO(2) surfaces at near-ambient temperatures...

Cite
Chen J, Franking R, Ruther RE, et al. Formation of molecular monolayers on TiO2 surfaces: a surface analogue of the Williamson ether synthesis. Langmuir. 2011;27(11):6879-89doi: 10.1021/la2008528.
Chen, J., Franking, R., Ruther, R. E., Tan, Y., He, X., Hogendoorn, S. R., & Hamers, R. J. (2011). Formation of molecular monolayers on TiO2 surfaces: a surface analogue of the Williamson ether synthesis. Langmuir : the ACS journal of surfaces and colloids, 27(11), 6879-89. https://doi.org/10.1021/la2008528
Chen, Jixin, et al. "Formation of molecular monolayers on TiO2 surfaces: a surface analogue of the Williamson ether synthesis." Langmuir : the ACS journal of surfaces and colloids vol. 27,11 (2011): 6879-89. doi: https://doi.org/10.1021/la2008528
Chen J, Franking R, Ruther RE, Tan Y, He X, Hogendoorn SR, Hamers RJ. Formation of molecular monolayers on TiO2 surfaces: a surface analogue of the Williamson ether synthesis. Langmuir. 2011 Jun 07;27(11):6879-89. doi: 10.1021/la2008528. Epub 2011 May 02. PMID: 21528935.
Copy Download .nbib Format: NLM
Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours.

Clinical sarcoma research

Verdegaal SH, Hartigh Jd, Hogendoorn PC, Brouwers HF, Taminiau AH.
PMID: 22588078
Clin Sarcoma Res. 2012 Mar 26;2(1):10. doi: 10.1186/2045-3329-2-10.

BACKGROUND: Phenol is widely used for years as local adjuvant treatment for bone tumours. Despite its use for a long time, no information is available about the local concentration of phenol that is achieved in an individual patient, and...

Cite
Verdegaal SH, Hartigh Jd, Hogendoorn PC, et al. Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours. Clin Sarcoma Res. 2012;2(1):10doi: 10.1186/2045-3329-2-10.
Verdegaal, S. H., Hartigh, J. d., Hogendoorn, P. C., Brouwers, H. F., & Taminiau, A. H. (2012). Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours. Clinical sarcoma research, 2(1), 10. https://doi.org/10.1186/2045-3329-2-10
Verdegaal, Suzan Hm, et al. "Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours." Clinical sarcoma research vol. 2,1 (2012): 10. doi: https://doi.org/10.1186/2045-3329-2-10
Verdegaal SH, Hartigh Jd, Hogendoorn PC, Brouwers HF, Taminiau AH. Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours. Clin Sarcoma Res. 2012 Mar 26;2(1):10. doi: 10.1186/2045-3329-2-10. PMID: 22588078; PMCID: PMC3351749.
Copy Download .nbib Format: NLM
Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH.

Clinical sarcoma research

Cliteur VP, Szuhai K, Baelde HJ, van Dam J, Gelderblom H, Hogendoorn PC.
PMID: 22587803
Clin Sarcoma Res. 2012 Jan 25;2(1):3. doi: 10.1186/2045-3329-2-3.

Desmoplastic small round cell tumour is a rare malignant tumour with a male to female ratio of 4:1. It manifests mostly at serosal sites. Here we present a case of a 28-year-old male patient, who presented with a fast...

Cite
Cliteur VP, Szuhai K, Baelde HJ, et al. Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH. Clin Sarcoma Res. 2012;2(1):3doi: 10.1186/2045-3329-2-3.
Cliteur, V. P., Szuhai, K., Baelde, H. J., van Dam, J., Gelderblom, H., & Hogendoorn, P. C. (2012). Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH. Clinical sarcoma research, 2(1), 3. https://doi.org/10.1186/2045-3329-2-3
Cliteur, Vincent Pm, et al. "Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH." Clinical sarcoma research vol. 2,1 (2012): 3. doi: https://doi.org/10.1186/2045-3329-2-3
Cliteur VP, Szuhai K, Baelde HJ, van Dam J, Gelderblom H, Hogendoorn PC. Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH. Clin Sarcoma Res. 2012 Jan 25;2(1):3. doi: 10.1186/2045-3329-2-3. PMID: 22587803; PMCID: PMC3351707.
Copy Download .nbib Format: NLM
Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Hereditary cancer in clinical practice

Hameetman L, Bovée JV, Taminiau AH, Kroon HM, Hogendoorn PC.
PMID: 20233460
Hered Cancer Clin Pract. 2004 Nov 15;2(4):161-73. doi: 10.1186/1897-4287-2-4-161.

Multiple Osteochondromas is an autosomal dominant disorder characterised by the presence of multiple osteochondromas and a variety of orthopaedic deformities. Two genes causative of Multiple Osteochondromas, Exostosin-1 (EXT1) and Exostosin-2 (EXT2), have been identified, which act as tumour suppressor...

Cite
Hameetman L, Bovée JV, Taminiau AH, et al. Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hered Cancer Clin Pract. 2004;2(4):161-73doi: 10.1186/1897-4287-2-4-161.
Hameetman, L., Bovée, J. V., Taminiau, A. H., Kroon, H. M., & Hogendoorn, P. C. (2004). Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hereditary cancer in clinical practice, 2(4), 161-73. https://doi.org/10.1186/1897-4287-2-4-161
Hameetman, Liesbeth, et al. "Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management." Hereditary cancer in clinical practice vol. 2,4 (2004): 161-73. doi: https://doi.org/10.1186/1897-4287-2-4-161
Hameetman L, Bovée JV, Taminiau AH, Kroon HM, Hogendoorn PC. Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hered Cancer Clin Pract. 2004 Nov 15;2(4):161-73. doi: 10.1186/1897-4287-2-4-161. PMID: 20233460; PMCID: PMC2840003.
Copy Download .nbib Format: NLM
MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation.

Genes & cancer

Baranski Z, Booij TH, Kuijjer ML, de Jong Y, Cleton-Jansen AM, Price LS, van de Water B, Bovée JV, Hogendoorn PC, Danen EH.
PMID: 26807203
Genes Cancer. 2015 Nov;6(11):503-12. doi: 10.18632/genesandcancer.91.

Conventional high-grade osteosarcoma is the most common primary bone cancer with relatively high incidence in young people. Recurrent and metastatic tumors are difficult to treat. We performed a kinase inhibitor screen in two osteosarcoma cell lines, which identified MEK1/2...

Cite
Baranski Z, Booij TH, Kuijjer ML, et al. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes Cancer. 2015;6(11):503-12doi: 10.18632/genesandcancer.91.
Baranski, Z., Booij, T. H., Kuijjer, M. L., de Jong, Y., Cleton-Jansen, A. M., Price, L. S., van de Water, B., Bovée, J. V., Hogendoorn, P. C., & Danen, E. H. (2015). MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes & cancer, 6(11), 503-12. https://doi.org/10.18632/genesandcancer.91
Baranski, Zuzanna, et al. "MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation." Genes & cancer vol. 6,11 (2015): 503-12. doi: https://doi.org/10.18632/genesandcancer.91
Baranski Z, Booij TH, Kuijjer ML, de Jong Y, Cleton-Jansen AM, Price LS, van de Water B, Bovée JV, Hogendoorn PC, Danen EH. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes Cancer. 2015 Nov;6(11):503-12. doi: 10.18632/genesandcancer.91. PMID: 26807203; PMCID: PMC4701229.
Copy Download .nbib Format: NLM
The genus .

ZooKeys

Leijs R, Batley M, Hogendoorn K.
PMID: 28331394
Zookeys. 2017 Feb 08;(653):79-140. doi: 10.3897/zookeys.653.11177. eCollection 2017.

The Australian bees in the subgenera

Cite
Leijs R, Batley M, Hogendoorn K. The genus . Zookeys. 2017;(653):79-140doi: 10.3897/zookeys.653.11177.
Leijs, R., Batley, M., & Hogendoorn, K. (2017). The genus . ZooKeys, (653), 79-140. https://doi.org/10.3897/zookeys.653.11177
Leijs, Remko, et al. "The genus ." ZooKeys vol. ,653 (2017): 79-140. doi: https://doi.org/10.3897/zookeys.653.11177
Leijs R, Batley M, Hogendoorn K. The genus . Zookeys. 2017 Feb 08;(653):79-140. doi: 10.3897/zookeys.653.11177. eCollection 2017. PMID: 28331394; PMCID: PMC5345376.
Copy Download .nbib Format: NLM
Hydrogen and Carbon Monoxide-Utilizing .

Frontiers in microbiology

Hogendoorn C, Pol A, Picone N, Cremers G, van Alen TA, Gagliano AL, Jetten MSM, D'Alessandro W, Quatrini P, Op den Camp HJM.
PMID: 32508778
Front Microbiol. 2020 May 19;11:951. doi: 10.3389/fmicb.2020.00951. eCollection 2020.

Volcanic and geothermal areas are hot and often acidic environments that emit geothermal gasses, including H

Cite
Hogendoorn C, Pol A, Picone N, et al. Hydrogen and Carbon Monoxide-Utilizing . Front Microbiol. 2020;11:951doi: 10.3389/fmicb.2020.00951.
Hogendoorn, C., Pol, A., Picone, N., Cremers, G., van Alen, T. A., Gagliano, A. L., Jetten, M. S. M., D'Alessandro, W., Quatrini, P., & Op den Camp, H. J. M. (2020). Hydrogen and Carbon Monoxide-Utilizing . Frontiers in microbiology, 11951. https://doi.org/10.3389/fmicb.2020.00951
Hogendoorn, Carmen, et al. "Hydrogen and Carbon Monoxide-Utilizing ." Frontiers in microbiology vol. 11 (2020): 951. doi: https://doi.org/10.3389/fmicb.2020.00951
Hogendoorn C, Pol A, Picone N, Cremers G, van Alen TA, Gagliano AL, Jetten MSM, D'Alessandro W, Quatrini P, Op den Camp HJM. Hydrogen and Carbon Monoxide-Utilizing . Front Microbiol. 2020 May 19;11:951. doi: 10.3389/fmicb.2020.00951. eCollection 2020. PMID: 32508778; PMCID: PMC7248562.
Copy Download .nbib Format: NLM
Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature.

Oxford medical case reports

Mremi A, Pyuza JJ, Ahmad B, Andongolile AA, Sadiq A, Yahaya JJ, Szuhai K, Hogendoorn PCW.
PMID: 33959300
Oxf Med Case Reports. 2021 Apr 28;2021(4):omab024. doi: 10.1093/omcr/omab024. eCollection 2021 Apr.

Lymphoma of bone is a rare neoplasm composed of malignant lymphoid cells, producing a tumefactive lesion within bone. We report a 13-year-old male who presented with progressively increasing swellings at the right shoulder and right mid-thigh for one month....

Cite
Mremi A, Pyuza JJ, Ahmad B, et al. Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature. Oxf Med Case Reports. 2021;2021(4):omab024doi: 10.1093/omcr/omab024.
Mremi, A., Pyuza, J. J., Ahmad, B., Andongolile, A. A., Sadiq, A., Yahaya, J. J., Szuhai, K., & Hogendoorn, P. C. W. (2021). Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature. Oxford medical case reports, 2021(4), omab024. https://doi.org/10.1093/omcr/omab024
Mremi, Alex, et al. "Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature." Oxford medical case reports vol. 2021,4 (2021): omab024. doi: https://doi.org/10.1093/omcr/omab024
Mremi A, Pyuza JJ, Ahmad B, Andongolile AA, Sadiq A, Yahaya JJ, Szuhai K, Hogendoorn PCW. Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature. Oxf Med Case Reports. 2021 Apr 28;2021(4):omab024. doi: 10.1093/omcr/omab024. eCollection 2021 Apr. PMID: 33959300; PMCID: PMC8082228.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 68 entries